Fingerprint
Dive into the research topics of 'Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment
Research output: Contribution to journal › Article › peer-review
31
Citations
(Scopus)